Concepts (183)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pulmonary Disease, Chronic Obstructive | 20 | 2024 | 3047 | 3.210 |
Why?
|
Idiopathic Pulmonary Fibrosis | 4 | 2023 | 451 | 1.490 |
Why?
|
Lung Diseases, Interstitial | 4 | 2023 | 808 | 0.840 |
Why?
|
Pulmonary Emphysema | 2 | 2024 | 672 | 0.670 |
Why?
|
Heparin | 3 | 2021 | 1637 | 0.610 |
Why?
|
Genome-Wide Association Study | 8 | 2023 | 12261 | 0.570 |
Why?
|
Genetic Markers | 2 | 2022 | 2634 | 0.520 |
Why?
|
Genetic Predisposition to Disease | 10 | 2023 | 17446 | 0.490 |
Why?
|
Lung | 12 | 2023 | 9856 | 0.470 |
Why?
|
Respiratory Function Tests | 5 | 2023 | 1616 | 0.410 |
Why?
|
Venous Thromboembolism | 2 | 2021 | 1671 | 0.400 |
Why?
|
Asthma | 4 | 2023 | 6011 | 0.400 |
Why?
|
Vital Capacity | 3 | 2023 | 925 | 0.380 |
Why?
|
Venous Thrombosis | 1 | 2020 | 1239 | 0.380 |
Why?
|
Intensive Care Units | 2 | 2021 | 3679 | 0.370 |
Why?
|
Disease Progression | 3 | 2023 | 13284 | 0.340 |
Why?
|
Forced Expiratory Volume | 3 | 2023 | 1743 | 0.330 |
Why?
|
Mucin-5B | 3 | 2023 | 141 | 0.320 |
Why?
|
Spirometry | 5 | 2022 | 864 | 0.320 |
Why?
|
Hypertension, Pulmonary | 4 | 2021 | 1537 | 0.310 |
Why?
|
Pulmonary Embolism | 1 | 2020 | 2376 | 0.300 |
Why?
|
Polymorphism, Single Nucleotide | 4 | 2023 | 15519 | 0.280 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3133 | 0.260 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3240 | 0.260 |
Why?
|
Multifactorial Inheritance | 2 | 2022 | 1194 | 0.250 |
Why?
|
Inflammation | 2 | 2023 | 10638 | 0.240 |
Why?
|
Antihypertensive Agents | 3 | 2020 | 2046 | 0.230 |
Why?
|
Phenotype | 7 | 2022 | 16365 | 0.220 |
Why?
|
Arthritis, Rheumatoid | 3 | 2023 | 3712 | 0.220 |
Why?
|
Anticoagulants | 4 | 2021 | 4599 | 0.220 |
Why?
|
Risk Factors | 11 | 2023 | 72290 | 0.200 |
Why?
|
Pulmonary Artery | 2 | 2020 | 1912 | 0.200 |
Why?
|
Humans | 47 | 2024 | 744343 | 0.200 |
Why?
|
Respiratory System Abnormalities | 1 | 2022 | 69 | 0.200 |
Why?
|
alpha 1-Antitrypsin | 1 | 2022 | 164 | 0.200 |
Why?
|
Risk Assessment | 2 | 2022 | 23338 | 0.190 |
Why?
|
Emphysema | 1 | 2024 | 247 | 0.190 |
Why?
|
Mitochondria, Liver | 1 | 2021 | 187 | 0.190 |
Why?
|
Drug Repositioning | 1 | 2023 | 229 | 0.190 |
Why?
|
Acetyltransferases | 1 | 2021 | 234 | 0.190 |
Why?
|
Prothrombin Time | 1 | 2020 | 119 | 0.180 |
Why?
|
Partial Thromboplastin Time | 1 | 2020 | 206 | 0.180 |
Why?
|
Epoprostenol | 1 | 2020 | 254 | 0.170 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2020 | 424 | 0.170 |
Why?
|
Telangiectasia, Hereditary Hemorrhagic | 1 | 2021 | 139 | 0.170 |
Why?
|
Anti-Asthmatic Agents | 1 | 2023 | 536 | 0.170 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2020 | 426 | 0.160 |
Why?
|
Enoxaparin | 1 | 2020 | 377 | 0.160 |
Why?
|
Ferritins | 1 | 2020 | 590 | 0.150 |
Why?
|
Internationality | 1 | 2022 | 1003 | 0.150 |
Why?
|
Fibrinogen | 1 | 2020 | 894 | 0.140 |
Why?
|
Sebaceous Glands | 1 | 2016 | 41 | 0.140 |
Why?
|
Severity of Illness Index | 4 | 2022 | 15540 | 0.140 |
Why?
|
Meta-Analysis as Topic | 1 | 2021 | 1344 | 0.140 |
Why?
|
Middle Aged | 14 | 2022 | 213383 | 0.130 |
Why?
|
Blood Coagulation | 1 | 2021 | 1127 | 0.130 |
Why?
|
Odds Ratio | 3 | 2022 | 9849 | 0.130 |
Why?
|
Heterozygote | 1 | 2022 | 2804 | 0.130 |
Why?
|
Interleukin-10 | 1 | 2020 | 1200 | 0.130 |
Why?
|
Predictive Value of Tests | 2 | 2022 | 15076 | 0.130 |
Why?
|
Acetamides | 1 | 2016 | 249 | 0.130 |
Why?
|
Sarcoidosis | 1 | 2020 | 506 | 0.120 |
Why?
|
rho-Associated Kinases | 1 | 2016 | 279 | 0.120 |
Why?
|
Propensity Score | 1 | 2021 | 1781 | 0.120 |
Why?
|
Antirheumatic Agents | 1 | 2023 | 1339 | 0.120 |
Why?
|
Pandemics | 4 | 2022 | 8388 | 0.120 |
Why?
|
Drugs, Investigational | 1 | 2015 | 214 | 0.110 |
Why?
|
Amides | 1 | 2016 | 459 | 0.110 |
Why?
|
Gene Expression Regulation | 2 | 2022 | 12072 | 0.110 |
Why?
|
Hypersensitivity, Immediate | 1 | 2016 | 337 | 0.110 |
Why?
|
Models, Genetic | 1 | 2022 | 3494 | 0.100 |
Why?
|
Adult | 12 | 2023 | 214055 | 0.090 |
Why?
|
Tomography, X-Ray Computed | 3 | 2022 | 20129 | 0.090 |
Why?
|
Male | 16 | 2023 | 350118 | 0.090 |
Why?
|
Genotype | 2 | 2023 | 12951 | 0.090 |
Why?
|
Interleukin-6 | 1 | 2020 | 3200 | 0.090 |
Why?
|
Pyrazines | 1 | 2016 | 1230 | 0.090 |
Why?
|
Female | 17 | 2023 | 380194 | 0.090 |
Why?
|
Vitamin D Deficiency | 1 | 2020 | 1343 | 0.090 |
Why?
|
Cohort Studies | 3 | 2022 | 40561 | 0.090 |
Why?
|
Genetic Variation | 2 | 2022 | 6544 | 0.090 |
Why?
|
Alcohol Drinking | 1 | 2022 | 3966 | 0.090 |
Why?
|
Cause of Death | 1 | 2020 | 3584 | 0.090 |
Why?
|
C-Reactive Protein | 1 | 2020 | 3778 | 0.080 |
Why?
|
Critical Care | 1 | 2021 | 2647 | 0.080 |
Why?
|
Plastids | 1 | 2007 | 7 | 0.080 |
Why?
|
Critical Illness | 1 | 2021 | 2670 | 0.080 |
Why?
|
Postprandial Period | 1 | 2009 | 292 | 0.080 |
Why?
|
Seeds | 1 | 2007 | 105 | 0.070 |
Why?
|
Ultrasonography | 1 | 2020 | 5985 | 0.070 |
Why?
|
Aged | 8 | 2022 | 163280 | 0.070 |
Why?
|
Pneumonia | 1 | 2018 | 2133 | 0.070 |
Why?
|
Plant Oils | 1 | 2007 | 202 | 0.070 |
Why?
|
Case-Control Studies | 2 | 2022 | 21746 | 0.070 |
Why?
|
Child | 3 | 2023 | 77709 | 0.070 |
Why?
|
Pyruvate Kinase | 1 | 2007 | 189 | 0.070 |
Why?
|
Prospective Studies | 4 | 2023 | 53288 | 0.070 |
Why?
|
Incidence | 2 | 2020 | 20947 | 0.060 |
Why?
|
Pyridines | 1 | 2016 | 2825 | 0.060 |
Why?
|
Arabidopsis | 1 | 2007 | 459 | 0.060 |
Why?
|
Sequence Analysis, RNA | 2 | 2022 | 2012 | 0.060 |
Why?
|
Genetic Loci | 2 | 2022 | 2575 | 0.060 |
Why?
|
Myostatin | 1 | 2023 | 124 | 0.050 |
Why?
|
Transcription Factors | 1 | 2022 | 12208 | 0.050 |
Why?
|
Logistic Models | 3 | 2022 | 13408 | 0.050 |
Why?
|
Genes, Overlapping | 1 | 2021 | 36 | 0.050 |
Why?
|
Triglycerides | 1 | 2009 | 2454 | 0.050 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2022 | 314 | 0.050 |
Why?
|
Biology | 1 | 2023 | 294 | 0.050 |
Why?
|
Linear Models | 2 | 2021 | 5952 | 0.050 |
Why?
|
Proteomics | 2 | 2024 | 3638 | 0.050 |
Why?
|
Molecular Epidemiology | 1 | 2022 | 468 | 0.050 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2018 | 5221 | 0.040 |
Why?
|
Sample Size | 1 | 2022 | 845 | 0.040 |
Why?
|
Treatment Outcome | 3 | 2020 | 63114 | 0.040 |
Why?
|
Mucin-1 | 1 | 2023 | 543 | 0.040 |
Why?
|
Cardiac Output | 1 | 2020 | 854 | 0.040 |
Why?
|
Vascular Resistance | 1 | 2020 | 936 | 0.040 |
Why?
|
Biological Specimen Banks | 1 | 2021 | 711 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2021 | 1677 | 0.030 |
Why?
|
Europe | 1 | 2022 | 3339 | 0.030 |
Why?
|
Cross-Sectional Studies | 3 | 2021 | 25043 | 0.030 |
Why?
|
Smoking | 2 | 2023 | 8987 | 0.030 |
Why?
|
Retrospective Studies | 2 | 2021 | 77449 | 0.030 |
Why?
|
Gene Expression Profiling | 2 | 2024 | 9438 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2018 | 13102 | 0.030 |
Why?
|
Brain Mapping | 1 | 2009 | 6669 | 0.030 |
Why?
|
Delayed-Action Preparations | 1 | 2016 | 968 | 0.030 |
Why?
|
Vasoconstriction | 1 | 2015 | 597 | 0.030 |
Why?
|
Monocytes | 1 | 2022 | 2596 | 0.030 |
Why?
|
Aged, 80 and over | 3 | 2022 | 57776 | 0.030 |
Why?
|
Genetic Association Studies | 1 | 2021 | 2703 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2016 | 1375 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2022 | 5867 | 0.020 |
Why?
|
Eosinophils | 1 | 2016 | 955 | 0.020 |
Why?
|
Hemodynamics | 1 | 2021 | 4199 | 0.020 |
Why?
|
Drug Design | 1 | 2015 | 1076 | 0.020 |
Why?
|
Cell Proliferation | 2 | 2016 | 10481 | 0.020 |
Why?
|
Immunoglobulin E | 1 | 2016 | 1463 | 0.020 |
Why?
|
United States | 3 | 2022 | 69872 | 0.020 |
Why?
|
Computer Simulation | 1 | 2022 | 6196 | 0.020 |
Why?
|
Survival Analysis | 1 | 2022 | 10252 | 0.020 |
Why?
|
Administration, Oral | 1 | 2016 | 3913 | 0.020 |
Why?
|
Time Factors | 2 | 2020 | 40075 | 0.020 |
Why?
|
Gene Expression | 1 | 2021 | 7799 | 0.020 |
Why?
|
Cotyledon | 1 | 2007 | 4 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2022 | 12354 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2020 | 4149 | 0.020 |
Why?
|
Genes, Plant | 1 | 2007 | 124 | 0.020 |
Why?
|
Prevalence | 1 | 2023 | 15226 | 0.020 |
Why?
|
Gene Expression Regulation, Plant | 1 | 2007 | 201 | 0.020 |
Why?
|
Vitamin D | 1 | 2020 | 3223 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2020 | 12245 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2022 | 13989 | 0.020 |
Why?
|
Chronic Disease | 1 | 2020 | 9146 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2015 | 2727 | 0.010 |
Why?
|
DNA, Complementary | 1 | 2007 | 2050 | 0.010 |
Why?
|
Multienzyme Complexes | 1 | 2007 | 686 | 0.010 |
Why?
|
Protein Subunits | 1 | 2007 | 959 | 0.010 |
Why?
|
Carbon | 1 | 2007 | 687 | 0.010 |
Why?
|
Glycolysis | 1 | 2007 | 827 | 0.010 |
Why?
|
Substrate Specificity | 1 | 2007 | 1801 | 0.010 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2016 | 4386 | 0.010 |
Why?
|
DNA, Bacterial | 1 | 2007 | 1465 | 0.010 |
Why?
|
Brain | 1 | 2009 | 26385 | 0.010 |
Why?
|
Animals | 3 | 2022 | 168757 | 0.010 |
Why?
|
Protein Transport | 1 | 2007 | 1988 | 0.010 |
Why?
|
Adolescent | 2 | 2022 | 85781 | 0.010 |
Why?
|
Dietary Fats | 1 | 2009 | 2017 | 0.010 |
Why?
|
Prognosis | 1 | 2020 | 29063 | 0.010 |
Why?
|
Kinetics | 1 | 2007 | 6473 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2016 | 9959 | 0.010 |
Why?
|
Cerebrovascular Circulation | 1 | 2009 | 2731 | 0.010 |
Why?
|
Quality of Life | 1 | 2020 | 12804 | 0.010 |
Why?
|
Lipid Metabolism | 1 | 2007 | 1889 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2007 | 6622 | 0.010 |
Why?
|
Young Adult | 1 | 2022 | 56430 | 0.010 |
Why?
|
Protein Binding | 1 | 2007 | 9386 | 0.010 |
Why?
|
Mice | 1 | 2022 | 81183 | 0.010 |
Why?
|
Signal Transduction | 1 | 2015 | 23403 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2009 | 8949 | 0.010 |
Why?
|
Mutation | 1 | 2007 | 29786 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2009 | 35421 | 0.000 |
Why?
|
Concepts
(183)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(93)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_